baber/WOPTO huggingface dataset:
Patent NZ-540522-A (NZ)
Title: Measured fill water dispenser for refrigerator freezers
Inventor: VOGLEWEDE RONALD L
IPC: F25B49/00
Filed: 2005-06-02
Abstract: A water dispenser 15 for a refrigerator freezer 10 including a measured fill mode of operation is disclosed. The dispenser has a water dispensing control 17, which in the measured fill mode dispenses a predetermined quantity of water. The control allows user selection of the units of measure, the type of container to be filled, selection of the amount to be dispensed, and a manual fill mode. A user display can display the selections and can display the amount dispensed in real time.
Patent NZ-542131-A (NZ)
Title: Method and apparatus to prevent medication error in a networked infusion system
Inventor: BONDERUD DAVID
IPC: G16H70/40
Filed: 2004-03-24
Abstract: Systems and methods for preventing delivery of a non-therapeutic dose of medication to a patient and/or preventing medications from being administered that would cause documented allergic or drug sensitivity reactions to the patient are disclosed. The networked medication delivery system 20 includes an infusion device 22 programmable by the user with instructions for administering the medication, and a computing device 26 for determining whether the programmed data would yield a clinically acceptable dose or whether the medication is in the list of documented medication that would cause an allergic or drug sensitivity reaction to the patient. The system may also include at least one monitor for displaying at least a portion of the programmed data, and an alerting device 28 for notifying medical personnel when the inputted dosage data are determined to yield a clinically unacceptable dose or when the medication is in the list of documented medications that would cause an allergic or drug sensitivity to the patient. The infusion device may be configured to become deactivated to prevent delivery of the medication when the dose is outside the therapeutic range or to prevent delivery of medication of documented allergic or drug sensitivity to a patient. Also included is a database 2) that may be remotely situated from the system 20 and accessed via a network 30.
Patent NZ-544270-A (NZ)
Title: Cancer combination therapy comprising AZD2171 and ZD1839
Inventor: WEDGE STEPHEN ROBERT
IPC: A61K41/00
Filed: 2004-07-08
Abstract: Disclosed is pharmaceutical composition which comprises AZD2171 or a pharmaceutically acceptable salt thereof, and ZD1839 or a pharmaceutically acceptable salt thereof, in association with a pharmaceutically acceptable excipient or carrier, wherein the composition is suitable for treating cancer; a kit comprising AZD2171 and ZD1839; and the use of AZD2171 and ZD1839 in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation.
Patent NZ-544362-A (NZ)
Title: A method of testing for the presence of cancer using aglyco products
Inventor: BOGOCH SAMUEL
IPC: C07K1/00
Filed: 1999-08-30
Abstract: An ex vivo method of testing for the presence of cancer associated with chronic viral disease comprising detecting transformation to malignant cells, wherein the transformation is detected by a determination of an elevated level of antibody which specifically recognises a peptide consisting of the sequence set forth in SEQ ID NO:1 or SEQ ID NO:2 or by aglycoprotein antigenic peptides in blood or tissue.
Patent NZ-549875-A (NZ)
Title: Disappearing interface system
Inventor: RUDOLPH JOHN R
IPC: F24C7/08
Filed: 2005-03-23
Abstract: A disappearing interface system for an appliance includes interface means for information exchange between a user and the interface system and control means, operatively connected to the interface means, for changing intensity of the light emitted from the light-emitting diode in response to a condition at the interface means. The interface means includes at least one light-emitting diode visible to the user when activated. The changing intensity of the light includes one of a gradual diminution or gradual increase in the visibility of light intensity. A cooking range containing the disappearing interface system is also disclosed. A cooking range comprises a user interface having a plurality of touch pad buttons and a microprocessor-based fader electronic control system. The user interface comprises an informational display area. The microprocessor-based fader electronic control system comprises a digitized exponential curve, a time-stepping algorithm to read data from the exponential curve, a pulse width modulated output signal generated by the microprocessor and controlled by the time-stepped algorithm, a digital to analog circuit driven by the pulse-Width modulated output signal, and an LED array located behind the user interface and driven by the digital to analog circuit. An LED fader electronic control system receives an input from the user interface and further processes the information to reduce or increase at least a portion of the light intensity of the LED array.
Patent NZ-549990-A (NZ)
Title: Methods for treating bone cancer pain by administering a nerve growth factor antagonist
Inventor: SHELTON DAVID L
IPC: C07K16/22
Filed: 2005-04-07
Abstract: Disclosed is the use of an antagonist of nerve growth factor (NGF) in the manufacture of a medicament for treating bone cancer pain.
Patent NZ-554337-A (NZ)
Title: Navigation system for disabled persons, in particular visually impaired persons
Inventor: SIRONI MARCO
IPC: A61H3/06
Filed: 2005-10-26
Abstract: A navigation system for disabled persons, in particular visually impaired persons, is disclosed. The system includes: a number of transponders with RFID tags installed at known locations, with each of the RFID tags having a unique identifier; a database including a mapping of the unique identifiers to the known locations; and a portable device having a transceiver for communication with at least one proximate transponder, a storage means for storing content of the database, a processing means for determining a known location in accordance with the mapping of the unique identifier of the proximate transponder and for determining information relating to the known location using the database, and an interface for providing the information. The transponders include animal identification RFID tags that have been recovered after prior use in an animal.
Patent NZ-556592-A (NZ)
Title: A method for preparing an undifferentiated cell
Inventor: ABDULJADAYEL IIHAM MOHAMED SALEH SAEED
IPC: A61K35/12
Filed: 2001-05-10
Abstract: A method of preparing an undifferentiated cell, the method comprising contacting a committed or partially committed cell in a buffy coat blood sample with an agent that causes the committed or partially committed cell to retrodifferentiate into an undifferentiated cell, and wherein the committed cells are non-cancer. (62) Divided Out of 540481
Patent NZ-564605-A (NZ)
Title: Immunogenic composition
Inventor: BIEMANS RALPH LEON
IPC: A61K39/095
Filed: 2006-06-23
Abstract: Provided is an immunogenic composition comprising at least 2 different Neisseria meningitidis capsular saccharides, wherein one or more is/are selected from a first group consisting of MenA, MenC, MenY and MenW which is/are conjugated to a protein carrier(s) wherein the saccharide:protein ratio (w/w) is between 1:2-1 :5, and one or more different saccharides is/are selected from a second group consisting of MenA, MenC, MenY and MenW which is/are conjugated to a protein carrier(s) wherein the saccharide:protein ratio (w/w) is between 5:1-1 :1.99 and wherein MenC is present and the ratio of Men C saccharide to carrier protein is between 1:2-1:5 (w/w). The composition can be used as a vaccine against Neisseria meningitides infection.
Patent NZ-564779-A (NZ)
Title: Automated system for precision cutting crooked lumber
Inventor: KOSKOVICH JEROME E
IPC: B26D1/00
Filed: 2006-06-28
Abstract: An automated saw system and method for cutting a crooked piece of lumber having a width, is disclosed. The automated saw system comprises a saw for cutting a piece of lumber at a cutting location; a conveyor located relative to the saw for feeding the piece of lumber to the saw along a conveyor axis where the lumber fed to the saw is cut through its width; a sensor for detecting a deviation amount by which the piece of lumber deviates from an idealised straight piece of lumber; a controller in communication with the sensor and at least one of the saw and the conveyor where the controller adjusts the position of at least one of the saw and the piece of lumber on the conveyor in response to the detected deviation amount, and an adjuster connected to the controller and the saw for varying a position of the saw relative to the conveyor in both a horizontal and vertical direction. This results in the piece of lumber being cut through its width to correspond to a cut of the idealised straight piece of lumber.
Patent NZ-566866-A (NZ)
Title: 9H-pyrido[2,3-b]indole compounds useful as Kinase inhibitors
Inventor: BROWN JASON W
IPC: A61K31/437
Filed: 2006-10-10
Abstract: Disclosed herein is are 9H-pyrido[2,3-b]indole compounds of formula (I) wherein the substituents are defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as kinase inhibitors and are therefore useful in the treatment of cancer, inflammation, inflammatory bowel disease, psoriasis or transplant rejection in a mammal.
Patent NZ-568026-A (NZ)
Title: Isoxazolines for controlling invertebrate pests
Inventor: LAHM GEORGE PHILIP
IPC: A01N43/80
Filed: 2006-12-28
Abstract: Disclosed are isoxazoline compounds of formula (1), wherein the variables are as defined in the specification. Also disclosed are compositions containing the isoxazoline compounds of formula (1) and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of said isoxazoline compound or a composition thereof. These isoxazoline compounds are suitable for controlling invertebrate pests such as a cockroach, an ant, a termite, a mosquito, a black fly, a stable, fly, a deer fly, a horse fly, a wasp, a yellow jacket, a hornet, a tick, a spider, an ant, or a gnat.
Patent NZ-571281-A (NZ)
Title: Processes and intermediates for preparing steric compounds
Inventor: TANOURY GERALD J
IPC: C07D303/48
Filed: 2007-03-14
Abstract: A process for preparing an optically enriched compound of Formula 1 wherein: the carbon atoms alpha and beta to the carboxy group are stereocenters; R1 is alkyl; R'1 is H; R'2 is -NHR2; R2 is alkyl or cycloalkyl; comprising the steps of: a) forming a salt of a compound of Formula 1 with an optically active organic acid selected from tartaric acid, malic acid, di-isopropylidenegulonic acid, and deoxycholic acid; and b) crystallizing said salt to give a compound of greater than 55% enantiomeric excess. Also disclosed are the intermediates N-cyclopropyl-3-propyloxirane-2-carboxamide and 3-azido-N-cyclopropyl-2-hydroxyhexanamide.
Patent NZ-579851-A (NZ)
Title: Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent
Inventor: YONEYAMA SHUJI
IPC: A61K31/00
Filed: 2008-03-26
Abstract: Disclosed is a solid pharmaceutical composition comprising (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{ [2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl} -1H-benzimidazole-7-carboxylate or a salt thereof, and a pH control agent having pH 2 to 5 and a process of preparation.
Patent NZ-580109-A (NZ)
Title: Arrangement for cooling of an electrical machine
Inventor: GUNDTOFT SOEREN
IPC: H02K9/04
Filed: 2009-10-01
Abstract: An arrangement for cooling an electrical machine is disclosed. The electrical machine comprises an outer rotor and an inner stator, where there is an air-gap between the rotor and the stator. The stator comprises a number of laminate plates having slots to support stator coil metal windings. The laminate-plates are fixed by two-endplates connected with the stator. Air cooling of the electrical machine is by a fan circulating air inside the electrical machine. A liquid cooling arrangement circulates cooling-liquid inside the electrical machine, where the fan and liquid cooling arrangements are connected by an air-to-liquid heat-exchanger adapted to transport heat out of the electrical machine by the cooling liquid. The air-to-liquid heat-exchanger and the fan are located between the stator and laminate end plates.
Patent NZ-584573-A (NZ)
Title: Heterocyclic compound and pharmaceutical composition thereof
Inventor: SUMIDA TAKUMI
IPC: A61K31/506
Filed: 2008-10-29
Abstract: Disclosed are heterocyclic compounds, or salts thereof, represented by general formula (I). Examples of the heterocyclic compound include: N-Dimethyl-M-[6-(2-{ 4-[4-(2,2,2-trifluoroethoxy)benzyl]piperazine-1-carbonyl} -1H-indol-6-yloxy)pyridin-3-yl]benzenesulfonamide, 3,4-Dichloro-N-(2-{ 2-[4-(4-isopropoxybenzyl)piperazine-1-carbonyl]-1-methyl-1H-indol-6-yloxy} pyrimidin-5-yl)-N-methylbenzenesulfonamide, and N-[6-(2-(4-[(4-Methoxybenzyl)methylamino]piperidine-1-carbonyll-1-methyl-1H-indol-5-yloxy)pyridin-3-yl]-4-trifluoromethylbenzamide. The compounds are used to treat fibrosis and tumours.
Patent NZ-589961-A (NZ)
Title: Crystal of spiroketal derivative, and process for production thereof
Inventor: MURAKATA MASATOSHI
IPC: C07H7/04
Filed: 2009-06-19
Abstract: Disclosed is a process for preparing a sprioketal compound of Formula (I) via a reaction between a tin-free organometallic reagent (such as organolithium reagents) and a lactone. Specific examples of compounds of Formula (I) include 1,1-anhydro-1-C-[5-(4-ethylphenyl)methyl-2-(hydroxymethyl)phenyl]-[beta]-D-glucopyranose. Compounds of Formula (I) are useful for treating diabetes.
Patent NZ-592480-A (NZ)
Title: Device for inserting or obtaining fluids in the oviduct of a sow including a beveled needle
Inventor: VAZQUEZ ROJAS JUAN MARIA
IPC: A61D19/02
Filed: 2009-09-24
Abstract: 592480 Disclosed is a device for inserting fluids in the oviduct of a sow comprising an injection system which is made up of a rigid external tubular body (1) that enables it to be inserted into the abdominal cavity of a sow. This body is, in turn, covered by a sterile sleeve (2) that enables it to be used in different animals. A flexible duct (3) runs coaxially and its distal end connects with a bevelled needle (4) that permits insertion in the oviduct (12) at an angle of 45°. The proximal end of the flexible tube connects with a device (6) that includes a sheath (7) closed at the other end by a piston (8) that slides along the inside of the sheath and that enables the precision insertion of low-volume liquids.
Patent NZ-592543-A (NZ)
Title: 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
Inventor: PATTERSON LORI JEAN
IPC: A61P25/00
Filed: 2009-11-13
Abstract: 592543 Disclosed are compounds of formula (I) where a, R1, and R3-6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula (I) are serotonin and norepinephrine reuptake inhibitors. Also disclosed are pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases. Examples of compounds of formula (I) are: 4-[4-Fluoro-2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine; 4-[2-(2,6-Difluorophenoxymethyl)phenyl]piperidine and 4-[2-(2,4,6-Trifluorophenoxymethyl)phenyl]piperidine.
Patent NZ-598241-A (NZ)
Title: Use of a composition to control the degree of heat induced foam generation in foodstuffs
Inventor: ELLIOT TERESA
IPC: A23L29/00
Filed: 2010-10-04
Abstract: Disclosed herein is the use of a composition to control the degree of heat induced foam generation in a foodstuff system when said foodstuff system is heated, wherein the composition comprises polyglycerol polyricinoleic acid, wherein the polyglycerol comprises one or a mixture of more than one of the polyglycerols selected from the group consisting of diglycerol, triglycerol, tetraglycerol, pentaglycerol, hexaglycerol, heptaglycerol, octaglycerol, nonaglycerol and decaglycerol, and wherein preferably, the composition is present in said foodstuff system in an amount of from about 0.01 to about 0.03% w/w based on the total weight of the foodstuff system.
Patent NZ-602312-A (NZ)
Title: Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
Inventor: HEISER ULRICH
IPC: C07D401/04
Filed: 2011-03-10
Abstract: 602312 The disclosure relates to heterocyclic derivatives as inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5). QC catalyzes the intramolecular cyclization of N-terminal glutamine residues into pyroglutamic acid (5-oxo-prolyl, pGlu*) under liberation of ammonia and the intramolecular cyclization of N-terminal glutamate residues into pyroglutamic acid under liberation of water. Conditions which may be treated by the compounds of the disclosure include: Kennedy’s disease, duodenal cancer with or without Helicobacter pylori infections, colorectal cancer, Zolliger-Ellison syndrome, gastric cancer with or without Helicobacter pylori infections, pathogenic psychotic conditions, schizophrenia, infertility, neoplasia, inflammatory host responses, cancer, malign metastasis, melanoma, psoriasis, impaired humoral and cell-mediated immune responses, leukocyte adhesion and migration processes in the endothelium, impaired food intake, impaired sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function, impaired hormonal balance or impaired regulation of body fluids, multiple sclerosis, the Guillain-Barré syndrome and chronic inflammatory demyelinizing polyradiculoneuropathy Compounds of the disclosure include: 3-(2,2,2-Trifluoroethoxy)-1-(1H-benzo[d]imidazol-5-yl)-5-(2,3-difluorophenyl)-4-methyl-1H-pyrrol-2(5H)-one, 3-(2,2,3,3-Tetrafluoropropoxy)-1-(1H-benzo[d]imidazol-5-yl)-5-(2,3-difluoro-phenyl)-4-methyl-1H-pyrrol-2(5H)-one, 1-(1 H-Benzo[d]imidazol-6-yl)-3-methoxy-4-methyl-5-(4-(1-methylpiperidin-4-yl)phenyl)-1H-pyrrol-2(5H)-one, 1-(1H-Benzo[d]imidazol-6-yl)-5-(4-(cyclohexyloxy)phenyl)-3-methoxy-4-methyl-1H-pyrrol-2(5H)-one, 1-(1H-Benzo[d]imidazol-6-yl)-5-(2,3-difluorophenyl)-3-methoxy-4-propyl-1H-pyrrol-2(5H)-one And 1-(1 H-Benzo[d]imidazol-6-yl)-5-cyclohexyl-3-methoxy-4-methyl-1H-pyrrol-2(5H)-one
Patent NZ-602540-A (NZ)
Title: Bioadhesive compositions of local anaesthetics
Inventor: SUNDBERG MARK
IPC: A61K9/00
Filed: 2011-03-31
Abstract: 602540 Disclosed is a pharmaceutical composition comprising: (a) 0.1 to 20% by weight of ropivacaine, bupivacaine, or levobupivacaine; (b) 15 to 70% by weight of either a monoglyceride or a diglyceride of a long chain fatty acid; (c) 5 to 60% by weight of a free long chain saturated or unsaturated fatty acid; and (d) less than 30% water; wherein, at least at a site of administration, the composition has an anisotropic organic phase behaviour that admits swelling of the composition with excess water at that site. Also disclosed is the use of the composition in the manufacture of a medicament for the treatment of pain in a subject. In particular obstetric and/or gynaecological procedures such as labour, application of IUDs, hysteroscopy, in vitro fertilization, spontaneous and legal abortions, and general vaginal examination, dental procedures, surgical procedures, such as skin grafting
Patent NZ-606232-A (NZ)
Title: Single-stranded nucleic acid molecule for controlling gene expression
Inventor: OHGI TADAAKI
IPC: C12N15/113
Filed: 2011-07-08
Abstract: Disclosed is an acyclic single-stranded ribonucleic acid molecule comprising only one expression inhibitory sequence that inhibits expression of a target gene and, in sequence from a 5’ side to a 3’ side, a 5’ side region (Xc), an inner region (Z) and a 3’ side 5 region (Yc) where: the inner region (Z) is composed of an inner 5’ side region (X) and an inner 3’ side region (Y) that are linked to each other; -the 5’ side region (Xc) is complementary to the inner 5’ side region (X); -the 3’ side region (Yc) is complementary to the inner 3’ side region (Y); -the inner region (Z) comprises the only one expression inhibitory sequence; -the 5’ side region (Xc) and the inner 5’ side region (X) are linked to each other via a linker region (Lx) which does not self-anneal inside itself; -the 3’ side region (Yc) and the inner 3’ side region (Y) are linked to each other via a linker region (Ly) which does not self-anneal inside itself; -the number of bases (Z) in the inner region (Z), the number of bases (X) in the inner 5’ side region (X), the number of bases (Y) in the inner 3’ side region (Y), the number of bases (Xc) in the 5’ side region (Xc), and the number of bases (Yc) in the 3’ side region (Yc) satisfy the following conditions: --Z = X + Y, --Z >= Xc + Yc, --Z - (Xc + Yc) is 0 to 10, --Z = 19 to 30, and --Xc = 1 to 7 or Yc = 1 to 9; and -the number of bases in each of the linker regions (Lx) and (Ly) is from 3 to 50.
Patent NZ-607978-A (NZ)
Title: Flexible cushioning pads, items incorporating such pads, and methods of making and using
Inventor: WYNER DANIEL M
IPC: B32B27/40
Filed: 2011-08-11
Abstract: Disclosed is a flexible or comformable cushioning protection pad where pockets of padding are grooved or channelled to allow the pads to more closely fit or mould the item being protected. The pads can be integrated into articles such as clothing garments and protective cases. The cushioning pad comprises a first channel comprising a thickness and a width, the first channel comprising a continuous upper layer and a continuous lower layer, the continuous upper layer at least partially bonded to the continuous lower layer. A cushioning region is adjacent to the first channel, the cushioning region having a thickness greater than the thickness of the first channel, the cushioning region further comprising a cushioning material disposed between and bonded to the continuous upper layer and the continuous lower layer. A groove is defined in the upper surface of the cushioning region, the groove comprising a thickness less than the thickness of the cushioning region and greater than the thickness of the first channel. The pad also comprises a perimeter flange and a perimeter channel, where the perimeter flange is spaced apart from the cushioning region by the width of the perimeter channel, where the perimeter flange has a thickness greater than the thickness of the perimeter channel and less than the thickness of the cushioning region. The perimeter flange comprises at least a portion of the cushioning material disposed between and bonded to the continuous upper layer and the continuous lower layer. The continuous upper layer is at least partially bonded to the continuous lower layer in the first channel by a plurality of portions of cushioning material disposed between and bonded to the continuous upper and lower layers. The first channel comprises a continuous layer of cushioning material disposed between and bonded to the continuous upper and lower layers.